ARCHIVES

Funding Opportunities.

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | March 22, 2002

Download PDF Visit The Full Archive

Related Articles

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

September 26, 2003

Modeling: Like The Sims But No Graphics

November 26, 2010

GAO Finds Little Wrong With Drug Testing Program, But Offers Some Suggestions Anyways

July 1, 1983

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

AIDS Biological Specimens Available From NIH

November 22, 1985

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013